Advertisement

Bio-Techne Corporation stock analysis📈, should we buy $TECH for dividends?

Bio-Techne Corporation stock analysis📈, should we buy $TECH for dividends? 🔥🔥🔥 My stock portfolio on Google docs FREE 👉
🎓🎓 My broker 👉
😱 Subscribe Now 👉

Bio-Techne Corporation have a very nice reports. I think it is a buy company.

The Company has three reportable segments based on the nature of its products; they are Biotechnology, Protein Platforms and Diagnostics.



The Company's Biotechnology segment is comprised of the legacy biotechnology business and ACD. These businesses manufacture consumables used for conducting laboratory experiments by both industry and academic scientists within the biotechnology and biomedical life science fields Our protein, antibodies, immunoassays, and small molecules products in the legacy biotechnology business are tools to help our customers analyze the protein component of cells, and the ACD technology allows our customers to analyze the genetic changes within cells. When used together, our customers have a more complete set of tools to study normal and abnormal cell behavior. No customer in the Biotechnology segment accounted for more than 10% of the segment’s net sales for the years ended June 30, 2018, 2017, and 2016.



The Company's Protein Platforms segment develops and commercializes proprietary systems and consumables for protein analysis. No customer in the Protein Platforms segment accounted for more than 10% of the segment’s net sales for the years ended June 30, 2018, 2017, and 2016.



The Company's Diagnostics reporting segment develops and manufactures a range of controls and calibrators used with diagnostic equipment and as proficiency testing tools, as well as other reagents incorporated into diagnostic kits. One customer accounted for approximately 12% for the fiscal year ended June 30, 2017. No customer in the Diagnostics segment accounted for more than 10% of the segment’s net sales for the fiscal years ended June 30, 2018 and 2016.



There are no concentrations of business transacted with a particular customer or supplier or concentrations of revenue from a particular product or geographic area that would severely impact the Company in the near term.




👍👍👍 Smash Like button 👍👍👍
😜😍😜 Instagram: stelmakdv 😜😍😜

NYSE,NASDAQ,stock market,dividens investing,passive income,finance,investing,stock,investment,market,stocks,how to invest,invest,income,dividend,dividend stocks,investor,monthly dividend stocks,buy and hold,dividend yield,stock market investing,stocks to buy,bio techne,bio-techne,bio-techne stock research,bio techne stock analysis,bio techne stock,tech stock,

Yorum Gönder

0 Yorumlar